Study Explores Liver Outcomes After HIV Treatment Switch - Top-Institutions - MDSpire

Study Explores Liver Outcomes After HIV Treatment Switch

PASO DOBLE sub-analysis reports steatosis differences at 96 weeks

  • March 5, 2026

  • 2 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • HIV Medicine
    • Hepatology
    • Infectious Diseases

  • #2

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • HIV Medicine
    • Hepatology
    • Clinical Research

  • #3

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • HIV Research

  • #4

    University of Barcelona
    University of Barcelona

    Barcelona, Catalonia

    Key Differentiators

    • HIV Medicine
    • Hepatology
    • Clinical Trials

  • #5

    ViiV Healthcare
    ViiV Healthcare

    London, UK

    Key Differentiators

    • Pharmaceutical Research
    • HIV Therapeutics

Original Source(s)

Study Explores Liver Outcomes After HIV Treatment Switch

  • March 5, 2026

Related Content

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

Medical Oddities: A Cancer Clue Some Patients Can’t See

This week’s science roundup shows how hidden signals can shape real outcomes.

Optimizing healthcare resources in pyogenic liver abscess: a dual-threshold HDL-CRP model for predicting hospitalization duration across multi-cohorts